anti-CD38 monoclonal antibody SCTC21C
Term · Oncology and biomedicine · MLC-T-ONC-010356
A monoclonal antibody that targets the cell surface glycoprotein CD38, with potential antineoplastic activity. Upon administration, anti-CD38 monoclonal antibody SCTC21C targets and binds to CD38 on CD38-positive tumor cells. This may kill, possiby through antibody-dependent cellular cytotoxicity (ADCC) or other responses, CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies.
| Identifier | MLC-T-ONC-010356 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010356",
"term": "anti-CD38 monoclonal antibody SCTC21C",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody that targets the cell surface glycoprotein CD38, with potential antineoplastic activity. Upon administration, anti-CD38 monoclonal antibody SCTC21C targets and binds to CD38 on CD38-positive tumor cells. This may kill, possiby through antibody-dependent cellular cytotoxicity (ADCC) or other responses, CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd38-monoclonal-antibody-sctc21c/"
}
Record 1,444 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.